Article

EURETINA LIVE: Research focuses on retinal issues following COVID-19 infection

Author(s):

A study detailed at the 22nd EURETINA Congress in Hamburg, Germany, documented a spectrum of manifestations following COVID-19 infections in an otherwise immunocompetent patient presenting at a tertiary care center.

Yusar Asad, MD, and colleagues from the Vitreoretinal Services, Centre for Sight, Delhi, India, pointed out that patients diagnosed with COVID-19 also presented with ocular issues. (Image courtesy of Adobe Stock)

Yusar Asad, MD, and colleagues from the Vitreoretinal Services, Centre for Sight, Delhi, India, pointed out that patients diagnosed with COVID-19 also presented with ocular issues. (Image courtesy of Adobe Stock)

Retinal involvement following a COVID-19 infection is rare but can happen after severe infections in immunocompetent individuals, according to Yusar Asad, MD, and colleagues from the Vitreoretinal Services, Centre for Sight, Delhi, India.

The research team conducted a retrospective review of consecutive patients presenting with retinal manifestations attributable to COVID 19 between May 2020 and June 2021. The study was detailed at the 22nd European Society of Retina Specialists (EURETINA) Congress in Hamburg, Germany.

The study included 20 eyes of 17 patients. All COVID-19 infections were confirmed by reverse transcriptase polymerase chain reaction. All other causes of retinal involvement were eliminated by systemic work-ups.

Asad reported that the patients presented with vascular involvement such as venous stasis retinopathy, central retinal vein occlusion (unilateral/bilateral), branch retinal artery occlusion, and anterior ischemic optic neuropathy as well as opportunistic infections like endogenous endophthalmitis, candidemia retinitis, and subretinal abscess in orbital mucormycosis.

“A whole spectrum of manifestations following COVID-19 infections in an otherwise immunocompetent patient presenting at a tertiary care center have been documented,” the investigators reported.

Investigators advised that clinicians should be aware of this spectrum of retinal involvement after COVID-19 infections and emphasized the importance of a fundus evaluation.

“While it is rare, it is important that these diseases can develop in a patient with visual symptoms,” Asad concluded.

Related Videos
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
© 2024 MJH Life Sciences

All rights reserved.